secwatch / observer
8-K filed June 12, 2026, 8:05 AM ET ticker MCK CIK 0000927653
debt confidence high sentiment neutral materiality 0.65

MCKESSON CORP (MCK): debt financing — McKesson subsidiary adds $2.25B senior secured term loan facility due 2032

MCKESSON CORP

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

MCKESSON CORP incurred term loan of $2,250.0 million with JPMorgan Chase Bank, N.A. as administrative agent and collateral agent at Adjusted Term SOFR Rate plus 2.25% per annum or Base Rate plus 1.25% per annum maturing due 2032.

Instrument
term loan
Principal
$2,250.0 million
Counterparty
JPMorgan Chase Bank, N.A. as administrative agent and collateral agent
Rate
Adjusted Term SOFR Rate plus 2.25% per annum or Base Rate plus 1.25% per annum
Maturity
due 2032
Event
incurrence
Exact text from the filing
On June 9, 2026, certain of McKesson Corporation’s (the “Company”) subsidiaries, including McKesson Medical-Surgical Top Holdings, Inc. (the “Borrower”), entered into an amendment (the “Amendment”) to the Credit Agreement , dated as of April 1, 2026, among, the Borrower, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent (as so amended, the “Credit Agreement”), to provide for a $2,250.0 million senior secured term “B” loan facility due 2032 (the “Term B Loan Facility”).
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

MCKESSON CORP amended Amendment to Credit Agreement, dated as of April 1, 2026 with JPMorgan Chase Bank, N.A. (as administrative agent) and other lenders valued at Term B loan facility of $2,250.0 million, interest at Adjusted Term SOFR + 2.25% or Base Rate + 1.25 (effective 2026-06-09).

Action
amendment
Agreement
credit facility
Counterparty
JPMorgan Chase Bank, N.A. (as administrative agent) and other lenders
Value
Term B loan facility of $2,250.0 million, interest at Adjusted Term SOFR + 2.25% or Base Rate + 1.25
Effective
2026-06-09
Exact text from the filing
On June 9, 2026, certain of McKesson Corporation’s (the “Company”) subsidiaries, including McKesson Medical-Surgical Top Holdings, Inc. (the “Borrower”), entered into an amendment (the “Amendment”) to the Credit Agreement , dated as of April 1, 2026, among, the Borrower, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent (as so amended, the “Credit Agreement”), to provide for a $2,250.0 million senior secured term “B” loan facility due 2032 (the “Term B Loan Facility”).
View on SEC.gov

295 debt financings filed in the last 30 days. Browse all debt financings →

MCKESSON CORP filing history →

Source: SEC EDGAR
accession 0000927653-26-000167
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.